Localized non‐Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients

AA Ezzat, EM Ibrahim, AN El Weshi… - Head & Neck …, 2001 - Wiley Online Library
Background Waldeyer's ring (WR) is the primary site of non‐Hodgkin's lymphoma (NHL)
involvement in approximately 5% to 10% of all lymphoma patients, and it accounts for more than …

Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors

…, AN El Weshi, AM Tulbah, MM Rahal, AA Ezzat - Acta …, 2006 - Taylor & Francis
Metaplastic carcinoma of the breast (MCB) is a rare form of cancer containing mixture of
epithelial and mesenchymal elements in variable combinations. Few and conflicting clinical data …

The present and the future of breast cancer burden in the Kingdom of Saudi Arabia

EM Ibrahim, AA Zeeneldin, BB Sadiq, AA Ezzat - Medical Oncology, 2008 - Springer
Background Despite the low cancer incidence in the Kingdom of Saudi Arabia (KSA), the
country must be ready to face the challenge of foreseeable increase in cancer burden …

Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population

AA Ezzat, EM Ibrahim, MA Raja, S Al-Sobhi, A Rostom… - Medical oncology, 1999 - Springer
In the Kingdom of Saudi Arabia (KSA), breast cancer constitutes 18% of all cancers in Saudi
women. Whilst locally advanced breast cancer disease is unusual in Western countries, it …

Breast cancer in the eastern province of Saudi Arabia

…, FA Al-Mulhim, A Al-Amri, FA Al-Muhanna, AA Ezzat… - Medical oncology, 1998 - Springer
In the Kingdom of Saudi Arabia (KSA), hospital and population based statistics have shown
that breast cancer has the highest crude frequency rate among Saudi women. The scarcity of …

High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin

AA Ezzat, EM Ibrahim, DS Ajarim, MM Rahal… - Breast cancer research …, 2000 - Springer
Background.In an earlier study, we have demonstrated a high response rate in metastatic
breast cancer using paclitaxel (P) and cisplatin (C). A phase II study using the same regimen (…

[PDF][PDF] Colorectal carcinoma from Saudi Arabia

KS Al-Kuraya, PP Bavi, AA Ezzat, FA Al-Dayel… - Saudi Med J, 2006 - academia.edu
Objective: To document the incidence and role of p53 and DNA mismatch repair proteins in
colorectal carcinomas, and to evaluate the relative frequency of major molecular pathways in …

Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer

…, DM Fatani, GA El-Husseiny, NB Elkum, AA Ezzat - Medical Oncology, 2010 - Springer
The objective of this study is to evaluate the efficacy and safety profile of the doxorubicin
followed by cisplatin/docetaxel as primary chemotherapy for patients with locally advanced …

Adjuvant chemotherapy in 780 patients with early breast cancer: 10-year data from Saudi Arabia

EM Ibrahim, AA Ezzat, MM Rahal, MM Raja, DS Ajarim - Medical oncology, 2005 - Springer
Background: By and large, data about adjuvant chemotherapy for breast cancer in the Middle
East are lacking. Retrospective analysis of prospectively captured data from a main referral …

HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer

AM Tulbah, EM Ibrahim, AA Ezzat, DS Ajarim… - Medical oncology, 2002 - Springer
Data about the prognostic and predictive value of HER-2/neu overexpression in patients
with locally advanced breast cancer (LABC) treated with primary chemotherapy is limited. …